Table 1 FACS analysis of control and ERG shRNA treated embryoid bodies.
From: ERG is required for the differentiation of embryonic stem cells along the endothelial lineage
| Â | Day 6 | Day 8 | Day 10 | |||
|---|---|---|---|---|---|---|
| Â | Control | ERG ShRNA | Control | ERG ShRNA | Control | ERG ShRNA |
CD 41 | 1.4% | 1.9% | 2.5% | 2.1% | 2.3% | 5.5% |
CD 45 | 0.8% | 1.3% | 0.7% | 0.5% | 2.4% | 3.1% |
VE-Cadherin | 5.8% | 1.5% | 19.3% | 10.4% | 26.8% | 5.7% |
Endoglin | 23.6% | 1.8% | 26.0% | 19.3% | 25.7% | 10.2% |
Tie2 | 10.5% | 9.3% | 19.6% | 17.4% | 20.6% | 13.2% |
VEGF-R1 | 26.6% | 25.9% | 34.9% | 25.4% | 21.8% | 16.4% |